Open access · US-GOV
via ClinicalTrials.gov Clinical trial
TRacking Alzheimer´s Disease: a Study of Disease trajeCtory and Development of Diagnostic and Disease Stage biomarKers in AD (TRACK-AD)
Authors not listed
Danish Dementia Research Centre · 2022
Abstract
This study will investigate the efficacy of novel biomarkers, namely blood-based biomarkers, pupillometry and actigraphy to track and predict progression of Alzheimer's disease (AD). Furthermore, the study will investigate the diagnostic value of pupillometry and actigraphy for AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2022). TRacking Alzheimer´s Disease: a Study of Disease trajeCtory and Development of Diagnostic and Disease Stage biomarKers in AD (TRACK-AD). <em>Danish Dementia Research Centre</em>. https://clinicaltrials.gov/study/NCT05175664
Vancouver
Anonymous. TRacking Alzheimer´s Disease: a Study of Disease trajeCtory and Development of Diagnostic and Disease Stage biomarKers in AD (TRACK-AD). Danish Dementia Research Centre. 2022.
BibTeX
@misc{anon2022TRacki,
title = {TRacking Alzheimer´s Disease: a Study of Disease trajeCtory and Development of Diagnostic and Disease Stage biomarKers in AD (TRACK-AD)},
author = {Anonymous},
journal = {Danish Dementia Research Centre},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Experimental & Clinical Medicine 2014
Preprint · CC-BY
Epigenomics of Alzheimer's Disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
medRxiv 2026
Open access · OA
Alzheimer’s disease blood biomarkers reveal proteomic modules of disease progression
Metabolic Brain Disease 2021
Citation only